Pancreas Cancer, Duct Cell Adenocarcinoma
5 clinical trials · Condition
◉ Watch Pancreas Cancer, Duct Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors (NCT07145255) | MBrace Therapeutics | 2025-09-03 |
| A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC (NCT06913218) | Akeso | 2025-07-22 |
| Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation (NCT07704021) | Azienda Unita Sanitaria Locale di Piacenza | 2022-04-01 |
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. (NCT05340569) | Laval University | 2022-03-28 |
| The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma (NCT05025371) | Iuliu Hatieganu University of Medicine and Pharmacy | 2021-04-01 |
Track Pancreas Cancer, Duct Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.